Hims & Hers (HIMS) Stock Surges 7% on Eli Lilly Weight Loss Drug Partnership Expansion

Hims & Hers (HIMS) stock surged 7% after expanding its Eli Lilly partnership to include Zepbound and other GLP-1 weight loss medications on its platform.

The post Hims & Hers (HIMS) Stock Surges 7% on Eli Lilly Weight Loss Drug Partnership Expansion appeared first on Blockonomi.